1,038 results on '"Thrift, Aaron P"'
Search Results
102. Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy
103. Recent Trends in the Incidence of Gastric Cancer in the United States.
104. Sex Differences in the Risk of Barrett’s Esophagus Associated With the Metabolic Effects of Obesity
105. Prior Diagnosis of Barrett’s Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival
106. The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans
107. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium
108. Racial/Ethnic Disparities in Cervical Cancer Stage at Diagnosis: Mediating Effects of Neighborhood-level Socioeconomic Deprivation
109. Abstract 1898: Racial/ethnic disparities in stage at diagnosis among women with cervical cancer in Texas: Mediating effects of neighborhood-level socioeconomic deprivation
110. Abstract 4211: Geospatial analyses identify hot spots of late-stage cervical cancer at diagnosis in Texas
111. Data from A Clinical Risk Prediction Model for Barrett Esophagus
112. Supplementary Table 1 from A Clinical Risk Prediction Model for Barrett Esophagus
113. Supplementary Tables S1-3 from Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk
114. Data from Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk
115. Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis
116. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis
117. Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett’s Esophagus
118. The epidemic of oesophageal carcinoma: Where are we now?
119. Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis
120. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014
121. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study
122. Epidemiology of Esophageal Adenocarcinoma
123. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score
124. Risk factors for HCC in contemporary cohorts of patients with cirrhosis
125. Polygenic Risk Scores for Follow Up After Colonoscopy and Polypectomy: Another Tool for Risk Stratification and Planning Surveillance?
126. Risk factors and populations at risk: Selection of patients for screening for Barrett's oesophagus
127. Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019
128. GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level
129. NAFLD-Related HCC: How Should the Shift in Epidemiology Change Our Prevention and Surveillance Strategies?
130. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey
131. Recent Trends in the Incidence of Gastric Cancer in the United States
132. Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics
133. Trends and Racial/Ethnic Differences in Predictors of Cervical Cancer Screening among US Women Ages 30–64 Years
134. Evolution of endoscopic mucosal resection (EMR) technique and the reduced recurrence of large colonic polyps from 2012 to 2020
135. Preventable causes of cancer in Texas by race/ethnicity: Major modifiable risk factors in the population
136. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality
137. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
138. Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization
139. A Multibiomarker Risk Score Helps Predict Risk for Barrett’s Esophagus
140. Can We Accurately Predict Survival in Patients With Perihilar Cholangiocarcinoma?
141. Are Non-HIV Malignancies Increased in the HIV-Infected Population?
142. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett’s Esophagus in Adults
143. Obesity in Relation to Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus
144. The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
145. Abstract 2280: Comparison of somatic mutations of whole exome sequencing data from black and white patients with esophageal adenocarcinoma
146. Abstract 5888: Trends in incidence of gallbladder cancer in all 50 United States from 2001 to 2018
147. Response to Swami et al.
148. External validation of a model determining risk of neoplastic progression of Barrett’s esophagus in a cohort of U.S. veterans
149. Can we really predict risk of cancer?
150. A Model to Determine Absolute Risk for Esophageal Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.